Recent Quotes (30 days)

You have no recent quotes
chg | %

Blackmores Limited  

(Public, ASX:BKL)   Watch this stock  
Find more results for ASX: BKL
136.28
+0.28 (0.21%)
Feb 23 - Close
ASX data delayed by 20 mins - Disclaimer
Currency in AUD
Range 136.00 - 138.50
52 week 86.27 - 178.00
Open 136.22
Vol / Avg. 174,908.00/49,120.00
Mkt cap 2.35B
P/E 40.07
Div/yield 1.40/1.98
EPS 3.40
Shares 17.23M
Beta     -
Inst. own     -
Feb 22, 2018
Interim 2018 Blackmores Ltd Earnings Release
Feb 22, 2018
Interim 2018 Blackmores Ltd Earnings Presentation - Webcast
  

Key stats and ratios

Q4 (Dec '17) 2017
Net profit margin 11.57% 10.56%
Operating margin 17.09% 15.69%
EBITD margin - 17.21%
Return on average assets 15.87% 13.57%
Return on average equity 38.15% 33.17%
Employees 1,000 -
CDP Score - -

Address

20 Jubilee Ave
SYDNEY, NSW 2102
Australia
+61-2-99105000 (Phone)
+61-2-99105555 (Fax)

Website links

Description

Blackmores Limited is engaged in the development, sales and marketing of health products for humans and animals, including vitamins, herbal and mineral nutritional supplements. The Company's segments include Australia, China (in-country), Other Asia, BioCeuticals and Other. The Company offers over 250 vitamins, minerals, herbal and nutritional supplements. BioCeuticals is a provider of healthcare practitioner nutritional and therapeutic supplements. Its product categories include pet health; infant formula; superfoods; arthritis, joint, bone and muscle; brain health; cold, flu and immunity; digestive health; energy and exercise; eye health; everyday health; fish and nutritional oils; heart and circulation; men's health; nails, hair and skin; pregnancy and pre-conception; stress relief, and weight management. Its products include Acidophilus Bifidus, Alive! Men's 50+ Multivitamin, Alive! Women's 50+ Multivitamin, Alive! Women's Multivitamin and Bilberry Eyestrain Relief.

Officers and directors

Richard Henfrey Chief Executive Officer, Managing Director
Aaron Canning Chief Financial Officer, Joint Company Secretary
Nathan A. Cheong Managing Director - BioCeuticals
David Fenlon Managing Director - Australia & New Zealand
Peter Osborne Managing Director - Asia
Lesley Braun Director of Blackmores Institute
Cecile Cooper CPA Company Secretary, Director - Corporate Affairs
Stephen John Chapman Independent Non-Executive Chairman of the Board
David Raymond Ansell Non-Executive Independent Director
John A. Armstrong Non-Executive Independent Director